Buprenorphine: a potential new treatment option for opioid dependence

Srivastava, Anita; Kahan, Meldon
June 2006
CMAJ: Canadian Medical Association Journal;6/20/2006, Vol. 174 Issue 13, p1835
Academic Journal
Presents research which discussed the use of buprenorphine as treatment for opioid dependence. Comparison between the efficacy of buprenorphine and methadone in treating patients that are dependent with opioid; Contributions of buprenorphine therapy to people experiencing opioid withdrawal symptoms; Effects of the therapy on the patients.


Related Articles

  • Safety and Efficacy of Buprenorphine/Naloxone in Opioid-Dependent Patients An Italian Observational Study. Magnelli, Fernanda; Biondi, Lorita; Calabria, Roberto; Fiore, Angelo; Peluso, Eugenio; Vonella, Domenico; Rota, Amerigo Giuseppe // Clinical Drug Investigation;2010 Supplement 1, Vol. 30, p21 

    Background Opioid dependence is a growing problem. Methadone is an established agent for the treatment of opioid dependence, but there is a risk of this agent being abused, a potential for interaction with antiretroviral agents and a risk of cardiac toxicity. Another option is the partial...

  • Buprenorphine: A more accessible treatment for opioid dependence. Flassing, Jason // JAAPA: Journal of the American Academy of Physician Assistants (;Sep2010, Vol. 23 Issue 9, p40 

    The article reports on the availability of buprenorphine for the treatment of opioid dependence in the U.S. in 2010. Buprenorphine offers relief of typical opioid withdrawal symptoms having fewer undesired impact than full agonists. Buprenorphine is more readily available in the setting of...

  • Comparative Trial to Study the Effectiveness of Clonidine Hydrochloride and Buprenorphine-Naloxone in Opioid Withdrawal - A Hospital Based Study. SAJAD HUSSAIN, SYED; FARHAT, SAMINA; HASSAN RAT, YASIR; ABBAS, ZAFFAR // Journal of Clinical & Diagnostic Research;Jan2015, Vol. 9 Issue 1, p1 

    Objectives: Prevalence of opioid addiction has alarmingly increased over the recent years. In South Asian region alone there are more than 10 million opioid abusers amounting to 2% of world population. Detoxification remains to be the first step for the successful treatment of opioid addiction....

  • Home Buprenorphine/Naloxone Induction in Primary Care. Lee, Joshua; Grossman, Ellie; DiRocco, Danae; Gourevitch, Marc N. // JGIM: Journal of General Internal Medicine;Feb2009, Vol. 24 Issue 2, p226 

    Buprenorphine can be used for the treatment of opioid dependence in primary care settings. National guidelines recommend directly observed initial dosing followed by multiple in-clinic visits during the induction week. We offered buprenorphine treatment at a public hospital primary care clinic...

  • Buprenorphine and a CRF1 Antagonist Block the Acquisition of Opiate Withdrawal-Induced Conditioned Place Aversion in Rats. Stinus, Luis; Cador, Martine; Zorrilla, Eric P.; Koob, George F. // Neuropsychopharmacology;Jan2005, Vol. 30 Issue 1, p90 

    Conditioned place aversion in rats has face validity as a measure of the aversive stimulus effects of opiate withdrawal that reflects an important motivational component of opiate dependence. The purpose of the present study was to validate conditioned place aversion as sensitive to medications...

  • Use of Ketamine in Ameliorating Opioid Withdrawal Symptoms During an Induction Phase of Buprenorphine. Omoigui, Sota; Hashmat, Fahad; Bernardo, Zeudi // Open Pain Journal;2011, Vol. 4, p1 

    Ketamine can be used in the treatment of opioid withdrawal symptoms. Here are two case discussions of treatment of withdrawal symptoms in opioid dependent patients undergoing detoxification. Our case reports endorse the hypothesis that N-methyl D-aspartate (NMDA) antagonists may selectively...

  • Benefits of Extended Duration Detoxification.  // Clinical Oncology Alert;Jan2009 Clinical Briefs, Vol. 14 Issue 1, p1 

    The article discusses research being done on extended versus short-term buprenorphine-naloxone for treatment of opioid-addicted youth. It references a study by G. E. Woody et al published in the 2008 issue of "JAMA." The study randomized opioid-addicted adults to either short-term buprenorphine...

  • Buprenorphine/naloxone withdrawal.  // Reactions Weekly;10/20/2012, Issue 1424, p17 

    The article describes the case of three men and one woman, aged 25-63 years, who developed mild opiate withdrawal after abrupt cessation of buprenorphine/naloxone maintenance therapy for opioid dependence.

  • Assessment of the sedative effects of buprenorphine administered with 20 µg/kg detomidine in horses. Love, E. J.; Taylor, P. M.; Murrell, J.; Whay, H. R.; Waterman-Pearson, A. E. // Veterinary Record: Journal of the British Veterinary Association;4/16/2011, Vol. 168 Issue 15, p408 

    The aim of this randomised, observer-blinded, crossover study was to compare the effects of four treatments, administered intravenously to six horses: saline and saline; 10 µg/kg detomidine and 7.5 µg/kg buprenorphine; 20 µg/kg detomidine and 7.5 µg/kg buprenorphine; and 20 µg/kg...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics